ABMD - Abiomed Inc. (ABMD) CEO Michael Minogue on Q4 2022 Results - Earnings Call Transcript

Abiomed, Inc. (ABMD) Q4 2022 Results Conference Call April 28, 2022 08:00 AM ET Company Participants Nicole Nath - Manager, Investor Relations Michael Minogue - President and Chief Executive Officer Todd Trapp - Vice President and Chief Financial Officer Conference Call Participants Matthew O’Brien - Piper Sandler Marie Thibault - BTIG Brandon Vazquez - William Blair & Company Danielle Antalffy - SVB Leerink Imron Zafar - Deutsche Bank Michael Polark - Wolfe Research Christopher Cooley - Stephens Inc Presentation Operator Hello, and a warm welcome to today’s Abiomed Fiscal Year 2022 Fourth Quarter Earnings Call. My name is Emma, and I will be coordinating the call today. [Operator Instructions] It is now my pleasure to hand today’s call over to Nicole Nath, Head of Investor Relations to begin. Over to you Nicole. Nicole Nath Good morning and welcome to Abiomed’s fourth quarter fiscal 2022 earnings conference call. This is Nicole

For further details see:

Abiomed, Inc. (ABMD) CEO Michael Minogue on Q4 2022 Results - Earnings Call Transcript